New Breast Cancer Treatment Revealed
The federal health officials have confirmed the first biotech drug for breast cancer treatment prior to surgery.
The approved medicine comes from Roche, and it is called Perjeta. Women diagnosed with an early-stage of breast cancer and have high risk of the cancer spreading throughout the body are candidates for Perjeta.
While surgical measures to remove tumors have been the first steps in cancer treatments of all types, Perjeta can be prescribed before any surgery is performed.
Confirmed with accelerated approval via the FDA, women who took Perjeta as an initial form of treatment were more apt to be cancer-free in 12 weeks than women who seek alternative routes of treatment.
What do you think of this first-ever, pre-surgery, cancer medication?